-Nobuyuki Enomoto Researcher Activity Profile

Research Author Detailed Information 

Nobuyuki Enomoto Publication Rate By Year

Nobuyuki Enomoto has published 3 paper(s) in 2006, 4 paper(s) in 2007, 6 paper(s) in 2008, for a total of 13 research publications in total.

Nobuyuki N Enomoto Author Information

LAST NAME: enomoto

FIRST NAME: nobuyuki

INITIALS: N

AFFILIATION:

Papers

Nobuyuki Enomoto's Publication Record

1. The role of leptin in progression of non-alcoholic fatty liver disease. Year Published: 2006
Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
2. Effect of low-molecular-weight heparin on the commitment of bone marrow cells to liver sinusoidal endothelial cells in CCl(4)-induced liver injury. Year Published: 2006
Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
3. Exacerbation of dietary steatohepatitis and fibrosis in obese, diabetic KK-A(y) mice. Year Published: 2006
Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
4. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. Year Published: 2007
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
5. Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1. Year Published: 2007
Department of Immunology, University of Yamanashi, Yamanashi 409-3898, Japan.
6. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. Year Published: 2007
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
7. Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity. Year Published: 2008
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
8. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. Year Published: 2007
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
9. Targeting lipid metabolism in the treatment of hepatitis C virus infection. Year Published: 2008
1First Department of Internal Medicine and 2Department of Microbiology, Faculty of Medicine, University of Yamanashi, Yamanashi, and 3Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
10. Targeting lipid metabolism in the treatment of hepatitis C virus infection. Year Published: 2008
First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Chuo, Japan.
11. [Anti-viral therapy of type C chronic hepatitis. 1. The current status of interferon therapy: evidence for the standard therapy] Year Published: 2008
12. The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy. Year Published: 2008
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-cho, Musashino-shi, Tokyo 180-8610, Japan.
13. Targeting lipid metabolism in the treatment of hepatitis C virus infection. Year Published: 2008
First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Chuo, Japan.